LogoLogoMSF Science Portal
  • My saved items
logo

© Médecins Sans Frontières

MSF Science Portal
About MSF Science Portal
About MSF
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use

v2.1.4829.produseast1

Journal Article > Research

Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial

Wassuna M, Njenga SN, Balasegaram M, Alexander N, Omollo R, Edwards T, Dorlo TPC, Musa B, Sharaf Ali MH, Elamin MY, Kirigi G, Juma R, Kip AE, Schoone GJ, Hailu ADE, Olobo J, Ellis SJ, Kimutai R, Wells S, Gasim Khalil EA, Wourgaft NS, Alves F, Musa AM
Download
Download
Abstract
SSG&PM over 17 days is recommended as first line treatment for visceral leishmaniasis in eastern Africa, but is painful and requires hospitalization. Combination regimens including AmBisome and miltefosine are safe and effective in India, but there are no published data from trials of combination therapies including these drugs from Africa.
Subject Area
infections, other
DOI
10.1371/journal.pntd.0004880
Published Date
14-Sep-2016
PubMed ID
27627654
Languages
English
Journal
PLOS Neglected Tropical Diseases
Volume / Issue / Pages
Volume 10, Issue 9
Issue Date
14-Sep-2016
Dimensions Badge